NCT01591668 A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C Status COMPLETED Phase PHASE1
NCT01590979 Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Status TERMINATED Phase NA
NCT01590654 A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection Status COMPLETED Phase PHASE1
NCT01590641 A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT01590615 Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy Status COMPLETED Phase N/A
NCT01585688 Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL Status TERMINATED Phase PHASE1/PHASE2
NCT01569295 Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) Status COMPLETED Phase PHASE3
NCT01565889 Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. Status COMPLETED Phase PHASE1/PHASE2
NCT01565850 D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults Status COMPLETED Phase PHASE2
NCT01559844 Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant Status COMPLETED Phase PHASE2
NCT01558830 Safety of Amiodarone and Ranolazine Together in Patients With Angina Status UNKNOWN Phase PHASE4
NCT01555164 A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT01546597 Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine Status COMPLETED Phase PHASE1
NCT01546558 Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Status COMPLETED Phase PHASE1
NCT01542788 Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon Status COMPLETED Phase PHASE3
NCT01539512 A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE3
NCT01539291 Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512) Status TERMINATED Phase PHASE3
NCT01533259 Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients Status COMPLETED Phase PHASE3
NCT01528865 Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01522651 Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation Status COMPLETED Phase PHASE2